A cell therapy developer with operations at the Philadelphia Navy Yard plans reduce its headcount by 33% next year as it ...

J&J filed a lawsuit Tuesday in the US District Court for the District of Columbia alleging the US Health Resources and ...

In 2025, if the plan has a deductible, the $35 will not count towards that amount, but it will count towards the $2,000 ...

The United States government stands as the largest employer in the nation. Here are 10 public sector jobs within federal ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study ... and business fronts,” said Stephen Brady, ...

The recent FDA approval of Aucatzyl for treating adult patients with ... Additionally, Autolus Therapeutics’ strategic launch plan is poised to maximize market penetration, with 30 key centers ready ...

Pfizer’s China 2030 plan includes $1B investment, collaboration with local biotech (National Business Daily ... mid-October launch for its alopecia drug Leqselvi in the U.S. will have to ...

Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ET. Company Participants. Alexandra Schilt - Vice President, Crescendo Commu ...

(Bloomberg) -- AstraZeneca Plc raised its annual forecast, driven by strong demand for its blockbuster cancer drugs, and ...

Responding to Law Enforcement and Safeguarding Your Interests - In this final installment of our series on government ...

Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...